| Deal Information |
|
||||
| Credit & Investment Research |
|
||||
| Market Research |
|
||||
| News |
|
||||
|
US - IN March ####, Amgen Inc, a biotechnology company, authorized the reupurchase, of up to $#.### mil of the company's common stock outstanding in open market transactions.…
|
|